Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.2201
Delayed Data
As of May 24
 0.00 / 0.00%
Today’s Change
0.14
Today|||52-Week Range
0.40
-6.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.5M1.7M623.0K336.0K
 
 
 
 
 
Depreciation And Amortization11.0K56.0K189.0K439.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses102.6M128.0M79.7M54.6M
 
 
 
 
 
Research And Development85.6M103.1M60.1M33.5M
 
 
 
 
 
Total Operating Expenses102.6M128.0M79.9M55.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-101.1M-126.3M-79.3M-54.7M
 
 
 
 
 
Extraordinary Credit449.0K15.7M17.9M0.00
 
 
 
 
Extraordinary Charge-34.0M0.00-8.3M-17.4M
 
 
 
 
Interest Expense On Debt996.0K4.2M3.8M5.5M
 
 
 
 
 
Other Expenses23.0K20.0K-6.7M4.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-135.6M-114.7M-80.2M-73.1M
 
 
 
 
 
Preferred Dividend0.000.000.00-1.3M
 
 
Net Income-135.6M-114.7M-85.9M-73.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS59.2M77.7M111.1M242.8M
 
 
 
 
 
Shares To Calculate EPS Diluted59.2M77.7M111.1M242.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.29-$1.48-$0.77-$0.31
 
 
 
 
 
EPS Diluted-$2.29-$1.48-$0.77-$0.31